Stocktoria
Zai Lab Ltd ZLAB
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-09-28
Chart by TradingView
3/9
Piotroski F — financial health
-3.61
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $457.2M | $397.6M | $266.7M | $212.7M | $144.3M |
| Operating income | -$229.4M | -$282.1M | -$366.6M | -$404.4M | -$700.1M |
| Net income | -$175.5M | -$257.1M | -$334.6M | -$443.3M | -$704.5M |
| Operating cash flow | -$150.8M | -$214.9M | -$198.2M | -$367.6M | -$549.2M |
| Free cash flow | -$158.9M | -$220.5M | -$205.4M | -$392.2M | -$567.5M |
| Total assets | $1.2B | $1.2B | $1.0B | $1.2B | $1.6B |
| Total liabilities | $456.9M | $344.9M | $240.2M | $174.5M | $230.0M |
| Shareholders' equity | $715.5M | $840.9M | $796.1M | $1.0B | $1.4B |
| Ratios | |||||
| Operating margin | -50.2% | -71.0% | -137.4% | -190.1% | -485.1% |
| Net margin | -38.4% | -64.7% | -125.5% | -208.4% | -488.2% |
| FCF margin | -34.8% | -55.5% | -77.0% | -184.4% | -393.3% |
| Return on assets | -15.0% | -21.7% | -32.3% | -36.3% | -43.8% |
| Return on equity | -24.5% | -30.6% | -42.0% | -42.4% | -51.1% |
| Current ratio | 2.45 | 3.51 | 4.63 | 8.04 | 7.78 |
| Revenue growth | 15.0% | 49.1% | 25.4% | 47.4% | 194.8% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 35,120 | $660,607 |
| RENAISSANCE TECHNOLOGIES LLC | 14,300 | $268,983 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -3.61 (distress)
- Working capital / assets 0.514
- Retained earnings / assets -2.242
- EBIT / assets -0.196
- Equity / liabilities 1.566
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001704292 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.